Inventor · disambiguated record
Cedric Szpirer
Also filed as: SZPIRER CEDRIC · SZPIRER CEDRIC YVES · SZPIRER CÉDRIC
7 granted patents·2 pending applications·22 citations·filing 2002–2016
79Inventor score
Top patents by PatentIndex Score
9 records- 0185US8877504B2Method for the selection of recombinant clones comprising a sequence encoding an antidote protein to toxic moleculeUNIV BRUXELLES·Filed 2013·Granted Nov 4, 2014·5 cites·6 claims
- 0276US8470580B2Method for the selection of recombination clones comprising a sequence encoding an antidote protein to a toxic moleculeGABANT PHILIPPE·Filed 2002·Granted Jun 25, 2013·8 cites·17 claims
- 0372US8318497B2Reversible, parallel and multitask cloning method and kitSZPIRER CEDRIC·Filed 2003·Granted Nov 27, 2012·7 cites·31 claims
- 0465US10718001B2Host cell for producing proteinsDELPHI GENETICS·Filed 2015·Granted Jul 21, 2020·2 cites·15 claims
- 0541US2005260585A1Poison/antidote genetic systems for the selection of genetically modified eucaryote cells or organismsSZPIRER CEDRIC·Filed 2003·Application pending·0 cites
- 0639US9920323B2Genetically modified phage and use thereofSZPIRER CEDRIC·Filed 2011·Granted Mar 20, 2018·0 cites·15 claims
- 0738US2014147890A1Genetically modified phage and use thereofSZPIRER CEDRIC·Filed 2012·Application pending·0 cites
- 0833US9309518B2Reversible, parallel and multitask cloning method and kitSZPIRER CÉDRIC·Filed 2012·Granted Apr 12, 2016·0 cites·12 claims
- 0924US10138289B2Method for producing antibody using “naked” expression vector expressing type II transmembrane fusion proteinDELPHI GENETICS SA·Filed 2016·Granted Nov 27, 2018·0 cites·8 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →